Establishment Labs Holdings (ESTA) EPS (Weighted Average and Diluted) (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly EPS (Weighted Average and Diluted) of -$0.45 in Q1 2026, down 462.5% quarter-over-quarter from -$0.08 in Q4 2025, and up 35.71% on a YoY basis from -$0.33 in Q1 2025.
Establishment Labs Holdings (ESTA) EPS (Weighted Average and Diluted) (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' EPS (Weighted Average and Diluted) history runs 10 years deep, the most recent figure standing at -$0.45 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 35.71% year-over-year to -$0.45; the TTM figure through Mar 2026 stood at -$1.48 (up 52.41% YoY), while the FY2025 annual figure was -$1.72, up 42.67% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.45 for Q1 2026 at Establishment Labs Holdings, down from -$0.08 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.08 in Q4 2025 to a low of -$1.52 in Q2 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.66 across 5 years, with a median of -$0.59 in 2024.
- The sharpest annual moves came in 2022 and 2025: EPS (Weighted Average and Diluted) sank 590.91% in 2022, then soared 93.33% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.55 in 2022, then plunged by 43.64% to -$0.79 in 2023, then plunged by 51.9% to -$1.2 in 2024, then jumped by 93.33% to -$0.08 in 2025, then sank by 462.5% to -$0.45 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.45 (Q1 2026), -$0.08 (Q4 2025), and -$0.38 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn | -0.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.45 |
| Dec 31, 2025 | -0.08 |
| Sep 30, 2025 | -0.38 |
| Jun 30, 2025 | -0.57 |
| Mar 31, 2025 | -0.70 |
| Dec 31, 2024 | -1.20 |
| Sep 30, 2024 | -0.59 |
| Jun 30, 2024 | -0.62 |
| Mar 31, 2024 | -0.58 |
| Dec 31, 2023 | -0.79 |
| Sep 30, 2023 | -1.12 |
| Jun 30, 2023 | -0.65 |
| Mar 31, 2023 | -0.48 |
| Dec 31, 2022 | -0.55 |
| Sep 30, 2022 | -0.76 |
| Jun 30, 2022 | -1.52 |
| Mar 31, 2022 | -0.24 |
| Dec 31, 2021 | -0.59 |
| Sep 30, 2021 | -0.61 |
| Jun 30, 2021 | -0.22 |